6B42
Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) 2'-deoxy-AMP complex at 1.13A resolution
「5KM7」から置き換えられました6B42 の概要
| エントリーDOI | 10.2210/pdb6b42/pdb |
| 分子名称 | Histidine triad nucleotide-binding protein 1, 2'-DEOXYADENOSINE-5'-MONOPHOSPHATE (3 entities in total) |
| 機能のキーワード | hint, histidine triad, hit, hydrolase |
| 由来する生物種 | Homo sapiens (Human) |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 14427.41 |
| 構造登録者 | |
| 主引用文献 | Maize, K.M.,Shah, R.,Strom, A.,Kumarapperuma, S.,Zhou, A.,Wagner, C.R.,Finzel, B.C. A Crystal Structure Based Guide to the Design of Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) Activated ProTides. Mol. Pharm., 14:3987-3997, 2017 Cited by PubMed Abstract: Nucleotide analogues that incorporate a metabolically labile nucleoside phosphoramidate (a ProTide) have found utility as prodrugs. In humans, ProTides can be cleaved by human histidine triad nucleotide binding protein 1 (hHint1) to expose the nucleotide monophosphate. Activation by this route circumvents highly selective nucleoside kinases that limit the use of nucleosides as prodrugs. To better understand the diversity of potential substrates of hHint1, we created and studied a series of phosphoramidate nucleosides. Using a combination of enzyme kinetics, X-ray crystallography, and isothermal titration calorimetry with both wild-type and inactive mutant enzymes, we have been able to explore the energetics of substrate binding and establish a structural basis for catalytic efficiency. Diverse nucleobases are well tolerated, but portions of the ribose are needed to position substrates for catalysis. Beneficial characteristics of the amine leaving group are also revealed. Structural principles revealed by these results may be exploited to tune the rate of substrate hydrolysis to strategically alter the intracellular release of the product nucleoside monophosphate from the ProTide. PubMed: 28968488DOI: 10.1021/acs.molpharmaceut.7b00664 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.13 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






